Covering current events in science, the environment, technology and health requires a context and reliable sources that respond quickly.
When science hits the headlines, we publish reactions, explanations, and in-depth analysis from reliable sources, capturing both the evidence and the debates. Our library of science journalism resources and the briefings may be of use to you. Consult our directory of research centres.
We are on the lookout for any controversial information about science (embargoed or not), in order to react with the agility the media needs. Sign up to receive our embargoed contents, all under the Creative Commons licence. Find out more about how we work here.
"At present, it is not possible to know exactly when and how a volcano may erupt," explains the National Geological Institute (IGN). In other words: it pays to be prepared. Even if you are a journalist. These resources make it easier.
Volcanic monitoring in the Canary Islands must be constant. Not only because the archipelago is "one of the most interesting active volcanic regions on the planet", according to the IGN, but above all because "volcanism in the Canary Islands poses a potential risk to some two million people" who live on the islands or visit them as tourists.
The monographs of the International Agency for Research on Cancer (IARC) cause controversy in the public debate when they analyze topics such as meat and cell phone radiation. Interpreting their work rigorously is not easy: in this guide we try to help contextualize their studies.
Reporting on vaccines is not easy, but in recent years many journalists have had to navigate studies and reports full of new terminology and concepts. In this guide, we attempt to clarify some of the most important points for accurate reporting on these medicines.
E-cigarettes and smokeless tobacco are alternatives to traditional tobacco that have grown in popularity in recent years. Proponents claim that they serve to "reduce harm" and help quit smoking, while opponents claim that there is no evidence of benefit and that they can introduce young people, non-smokers and ex-smokers to tobacco.
The European spacecraft that was to investigate whether Mars harboured life in the past will no longer fly. The satellite that was to study dark energy in the universe is delayed and a robotic telescope at the Teide Observatory stops working. Europe used to spend tens of millions of euros on scientific collaboration with Russia. But no more.
Today the International Space Station (ISS) is completely dependent on Russia to keep it in orbit. Space X spacecraft, which NASA contracts, carry astronauts but cannot propel the ISS to maintain its altitude. A new American spacecraft, Cygnus, which has already conducted a successful propulsion test, is expected to be able to do so.
The Joint European Torus (JET) has achieved a relevant scientific milestone related to energy production from nuclear fusion reactions. The results confirm some of the technological options selected for the large international ITER experiment. Spain has proposed to build a scientific facility in Granada to develop materials with which to build future reactors.
More than two million doses of the vaccine from US company Novavax are expected to arrive in Spain soon. Nuvaxovid, or NVX-CoV2373, became the fifth vaccine approved in Europe against covid-19 on 20 December. We tell you how it differs from those already available, how it is produced and why it is especially important for countries with fewer resources.
The WHO recommends keeping an eye on the BA.2 variant of Omicron because it is spreading, but it does not appear to cause more serious disease or escape vaccination. Don't be fooled by its evocative nickname: it is perfectly detectable. The misconception that tests do not identify it was propagated by a headline that was corrected.